• COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
Buy Tests
  • COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
  • BUY TESTS
New HHS Secretary & COVID-19: What to Expect in 2025

New HHS Secretary & COVID-19: What to Expect in 2025

by Oceanit | Feb 11, 2025 | Future, Government, National News

New HHS Secretary & COVID-19: What to Expect in 2025 As of February 11, 2025, the U.S. Department of Health and Human Services (HHS) is awaiting the confirmation of a new Secretary under President Donald Trump’s administration. President Trump has nominated...
COVID-19 in February 2025: Updated Symptoms, Testing Recommendations, and Treatment Options

COVID-19 in February 2025: Updated Symptoms, Testing Recommendations, and Treatment Options

by Oceanit | Feb 5, 2025 | Education, Government

COVID-19 in February 2025: Updated Symptoms, Testing Recommendations, and Treatment Options As of February 2025, COVID-19 continues to impact communities worldwide. Staying updated on the latest symptoms, testing guidance, and treatment options is essential for...
Anticipated COVID-19 and Vaccine Policies Under 2025 Trump Administration

Anticipated COVID-19 and Vaccine Policies Under 2025 Trump Administration

by Oceanit | Feb 4, 2025 | Future, Government

Anticipated COVID-19 and Vaccine Policies Under 2025 Trump Administration As the new administration takes office in 2025, significant shifts in COVID-19 and vaccination policies are expected, reflecting the leadership’s perspectives and priorities. These changes may...
Could Vaccine Skepticism Under the New Administration Lead to a COVID Surge?

Could Vaccine Skepticism Under the New Administration Lead to a COVID Surge?

by Oceanit | Jan 31, 2025 | Future, General, Government

Could Vaccine Skepticism Under the New Administration Lead to a COVID Surge? With the transition to a new administration, concerns have emerged regarding potential shifts in public health messaging around COVID-19 vaccinations. If confidence in mRNA vaccines...
RFK Jr.’s Confirmation Hearings: Vaccine Views Under Scrutiny

RFK Jr.’s Confirmation Hearings: Vaccine Views Under Scrutiny

by Oceanit | Jan 31, 2025 | Government, National News

RFK Jr.’s Confirmation Hearings: Vaccine Views Under Scrutiny On January 30, 2025, Robert F. Kennedy Jr., nominated by President Donald Trump for Secretary of Health and Human Services (HHS), faced rigorous questioning during his Senate confirmation hearings. Kennedy,...
U.S. Intelligence Agencies Consider Lab Leak as Likely COVID-19 Origin

U.S. Intelligence Agencies Consider Lab Leak as Likely COVID-19 Origin

by Oceanit | Jan 29, 2025 | General, Government, International News

U.S. Intelligence Agencies Consider Lab Leak as Likely COVID-19 Origin In recent developments, several U.S. intelligence agencies, including the Central Intelligence Agency (CIA), have revised their assessments regarding the origins of COVID-19, now considering a...
« Older Entries
Next Entries »

Recent Posts

  • New 2025 COVID Vaccine Rules: What They Mean for Americans
  • Summer 2025 COVID Trends: What to Know & How to Stay Safe
  • CDC Updates 2025 COVID-19 Testing, Isolation & Recovery
  • WHO Pandemic Treaty Aims to Prevent Future Health Crises
  • Should You Keep Rapid Tests for Spring & Summer 2025?

Recent Comments

No comments to show.
Copyright 2025 Oceanit Foundry LLC. The ASSURE-100 Rapid COVID-19 Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
[dsm_icon_list list_alignment=”flex-end” _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” list_alignment_last_edited=”on|phone” list_alignment_phone=”center” sticky_enabled=”0″ list_alignment_tablet=”flex-end”][dsm_icon_list_child text=”Privacy Policy” use_icon=”off” url=”/privacy-policy/” _builder_version=”4.27.4″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_text_color=”#e8e8e8″ text_font_size=”12px” text_text_color_last_edited=”off|desktop” global_colors_info=”{}” text_text_color__hover_enabled=”on|desktop” text_text_color__hover=”#1e73be”][/dsm_icon_list_child][/dsm_icon_list]